What is he best known for?
The fields of study he is best known for:
Lloyd J. Old mostly deals with Antigen, Immunology, Antibody, Cancer and Molecular biology.
His study in Antigen is interdisciplinary in nature, drawing from both Virology, Melanoma, Cytotoxic T cell, Cancer/testis antigens and Monoclonal antibody.
Much of his study explores Immunology relationship to Cancer research.
His Cancer research research integrates issues from Tumor necrosis factor alpha and Breast cancer.
The Cancer study combines topics in areas such as Serology and Gene expression.
His research investigates the connection between Molecular biology and topics such as Cell culture that intersect with issues in Cell type and Pan-T antigens.
His most cited work include:
- An endotoxin-induced serum factor that causes necrosis of tumors (3764 citations)
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
- Cancer immunoediting: from immunosurveillance to tumor escape. (3414 citations)
What are the main themes of his work throughout his whole career to date?
Lloyd J. Old spends much of his time researching Antigen, Immunology, Antibody, Molecular biology and Cancer.
His studies deal with areas such as Cytotoxic T cell, Monoclonal antibody, Pathology and Virology as well as Antigen.
His research brings together the fields of Cancer research and Immunology.
His work carried out in the field of Antibody brings together such families of science as Melanoma, Recombinant DNA and NY-ESO-1.
In his study, In vivo is strongly linked to In vitro, which falls under the umbrella field of Molecular biology.
Cancer is a subfield of Internal medicine that Lloyd J. Old investigates.
He most often published in these fields:
- Antigen (54.36%)
- Immunology (35.34%)
- Antibody (33.87%)
What were the highlights of his more recent work (between 2004-2021)?
- Antigen (54.36%)
- Immunology (35.34%)
- Cancer (22.45%)
In recent papers he was focusing on the following fields of study:
Antigen, Immunology, Cancer, Antibody and Immune system are his primary areas of study.
Lloyd J. Old has researched Antigen in several fields, including Immunohistochemistry, Pathology, Cancer/testis antigens and NY-ESO-1.
Lloyd J. Old combines subjects such as Cytotoxic T cell and Cancer research with his study of Immunology.
His research in Cancer focuses on subjects like Oncology, which are connected to Phases of clinical research.
His research is interdisciplinary, bridging the disciplines of Molecular biology and Antibody.
His work deals with themes such as Virology, Vaccination and Melanoma, which intersect with Immune system.
Between 2004 and 2021, his most popular works were:
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
- Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer (1739 citations)
- Antibody therapy of cancer (1343 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Immunology, Antigen, Cancer, Immune system and Cytotoxic T cell.
His Antigen research is multidisciplinary, relying on both Cancer research, Melanoma, Antibody and Cancer/testis antigens.
The concepts of his Cancer research study are interwoven with issues in Transfection and Cell growth.
His studies in Cancer integrate themes in fields like Clinical trial, Oncology and Carcinoma.
His research in Immune system intersects with topics in Carcinogenesis and Transplantation.
His Cytotoxic T cell study combines topics in areas such as Priming and Immunization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
